Home › Funds › DAFNA Capital Management LLC › LXEO

DAFNA Capital Management LLC position in LXEO

LEXEO THERAPEUTICS INC COM · Health Care

DAFNA Capital Management LLC reported holding 377,059 shares of LXEO (LEXEO THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.33% of its reported portfolio and ranking #49 among its reported holdings. DAFNA Capital Management LLC has disclosed LXEO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)377.06K sh
Reported value held$1.76M
Portfolio Weight0.33%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's LXEO position evolved

DAFNA Capital Management LLC first disclosed a stake in LXEO in Q3 2024 at 250,583 shares (US$2.3M). The position peaked in Q4 2025 at 340,859 shares, worth US$3.4M. Across 8 filings, DAFNA Capital Management LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 377,059 shares valued at US$1.8M. Notable position changes include a 57% increase in Q4 2024 (shares fell 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 250.58K $2.27M New
Q4 2024 393.08K $2.59M Add
Q1 2025 378.08K $1.31M Reduce
Q2 2025 378.08K $1.52M Hold
Q3 2025 358.08K $2.38M Reduce
Q4 2025 340.86K $3.38M Reduce
Q1 2026 377.06K $2.16M Add
Q2 2026 377.06K $1.76M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LXEO and 13F data

LXEO (LEXEO THERAPEUTICS INC COM) is a Health Care company. 40 other funds we track also report a position in LXEO — the largest reported positions include MONTANOVA CAPITAL, LLC (US$29.7M), Affinity Asset Advisors, LLC (US$27.0M), Frazier Life Sciences Management, L.P. (US$22.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LXEO

All LXEO fund holders →

FAQ

How long has DAFNA Capital Management LLC held LXEO?

DAFNA Capital Management LLC has disclosed LXEO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is DAFNA Capital Management LLC's current position in LXEO?

As of Q2 2026, DAFNA Capital Management LLC holds 377.06K shares of LXEO (LEXEO THERAPEUTICS INC COM), valued at $1.76M, representing 0.33% of its reported portfolio and ranking #49.

Has DAFNA Capital Management LLC been buying or selling LXEO?

In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC held unchanged its position in LXEO. The position peaked in Q4 2025 at 340.86K shares.

Which other funds hold LXEO?

Other major institutional holders of LXEO include MONTANOVA CAPITAL, LLC, Affinity Asset Advisors, LLC, Frazier Life Sciences Management, L.P., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.